CU20150028A7 - QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS - Google Patents

QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS

Info

Publication number
CU20150028A7
CU20150028A7 CUP2015000028A CU20150028A CU20150028A7 CU 20150028 A7 CU20150028 A7 CU 20150028A7 CU P2015000028 A CUP2015000028 A CU P2015000028A CU 20150028 A CU20150028 A CU 20150028A CU 20150028 A7 CU20150028 A7 CU 20150028A7
Authority
CU
Cuba
Prior art keywords
derived
formula
amina
quinolin
quinoxaline
Prior art date
Application number
CUP2015000028A
Other languages
English (en)
Other versions
CU24319B1 (es
Inventor
Jamal Tazi
Florence Mahuteau
Romain Najman
Original Assignee
Centre Nat Rech Scient
Univ Montpellier 2
Inst Curie
Abivax
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20090305540 external-priority patent/EP2266972A1/en
Application filed by Centre Nat Rech Scient, Univ Montpellier 2, Inst Curie, Abivax filed Critical Centre Nat Rech Scient
Priority claimed from PCT/IB2010/052652 external-priority patent/WO2010143170A2/en
Publication of CU20150028A7 publication Critical patent/CU20150028A7/es
Publication of CU24319B1 publication Critical patent/CU24319B1/es

Links

Landscapes

  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un compuesto de fórmula (I) o sales farmacéuticamente aceptables de los mismos, donde las sales farmacéuticamente aceptables son seleccionadas de hidrobromada, tartrato, citrato, trifluoroacetato, ascorbato, hidroclorido, tartrato, triflato, maleato, mesilato, formato, acetato y fumarato El cual es alternativamente seleccionado de entre un compuesto de fórmula Ik y un compuesto Ip.
CUP2015000028A 2009-06-12 2010-06-14 QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS CU24319B1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18654409P 2009-06-12 2009-06-12
EP20090305540 EP2266972A1 (en) 2009-06-12 2009-06-12 New chemical molecules that inhibit the splicing mechanism for treating diseases resulting from splicing anomalies
PCT/IB2010/052652 WO2010143170A2 (en) 2009-06-12 2010-06-14 Compounds useful for treating premature aging and in particular progeria

Publications (2)

Publication Number Publication Date
CU20150028A7 true CU20150028A7 (es) 2015-11-27
CU24319B1 CU24319B1 (es) 2018-02-08

Family

ID=55659614

Family Applications (3)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (es) 2009-06-12 2010-06-14 QUINOLIN Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ii), (Ij), (Ij'), (Ij'') y (Ij''') Y SALES DERIVADAS
CUP2015000028A CU24319B1 (es) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS
CUP2015000025A CU24322B1 (es) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVADOS DE LA FÓRMULA (Ig) Y SALES DERIVADAS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (es) 2009-06-12 2010-06-14 QUINOLIN Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ii), (Ij), (Ij'), (Ij'') y (Ij''') Y SALES DERIVADAS

Family Applications After (1)

Application Number Title Priority Date Filing Date
CUP2015000025A CU24322B1 (es) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVADOS DE LA FÓRMULA (Ig) Y SALES DERIVADAS

Country Status (1)

Country Link
CU (3) CU24323B1 (es)

Also Published As

Publication number Publication date
CU20150027A7 (es) 2015-11-27
CU24319B1 (es) 2018-02-08
CU24323B1 (es) 2018-02-08
CU24322B1 (es) 2018-02-08
CU20150025A7 (es) 2015-11-27

Similar Documents

Publication Publication Date Title
CU24461B1 (es) Compuestos útiles para tratar envejecimiento prematuro y en particular progeria
NL301202I2 (nl) Linzagolix, of een farmaceutisch aanvaardbaar zout daarvan, zoals linzagolix choline
DE602004016127D1 (de) Antagonisten der opioidrezeptoren
ATE519764T1 (de) Spiroindolinon-derivate
NO20091395L (no) Nye tiofenderivater
LU92640I2 (fr) Florfenicol, ou son ester pharmaceutiquement acceptable, ou son sel pharmaceutiquement acceptable, avec betamethasone, ou son ester pharmaceutiquementacceptable
ATE377589T1 (de) 6-substituierte nikotinamidderivate als opioidrezeptorantagonisten
ATE446962T1 (de) Thiazolopyridinon-derivate als mch- rezeptorantagonisten
WO2008005368A3 (en) Piperazines as p2x7 antagonists
MX2009008541A (es) Fenilcarbamatos macrociclicos que inhiben el virus de hepatitis c.
MX2009004662A (es) Compuestos de pirazolina como antagonistas receptores de mineralocorticoides.
ATE545413T1 (de) Antagonisten des opioidrezeptors
ITRM20090498A1 (it) Testa di supporto per telecamere per riprese cinematografiche, televisive e simili .
ATE308522T1 (de) Opioidrezeptorantagonisten
DK1828177T3 (da) Hidtil ukendte MCH-receptorantagonister
ATE537822T1 (de) Antidepressivum
SV2010003725A (es) Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
JO3192B1 (ar) مركب بنزوثيازولون
IN2012DN02555A (es)
CU20150028A7 (es) QUINOLIN-2-AMINA Y QUINOXALINA DERIVADOS DE LA FÓRMULA (Ik) y (Ip) Y SALES DERIVADAS
BRPI0509014A (pt) comprimidos desintegráveis que compreendem licarbazepina
TW200719901A (en) Therapeutic substituted cyclopentanones
WO2004066950A3 (en) Quinoline derivatives as nk-2 and nk-3 receptor antagonists
WO2005000247A3 (en) 4-carboxamido quinoline derivatives for use as nk-2 and nk-3